Beam Therapeutics (BEAM)
(Delayed Data from NSDQ)
$22.93 USD
+1.02 (4.66%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $22.93 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO11/5/24 |
---|---|
Current Quarter | -1.13 |
EPS Last Quarter | -1.11 |
Last EPS Surprise | 1.77% |
ABR | 1.94 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.60 |
Next Year | -4.43 |
EPS (TTM) | -1.81 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 14.86M | 15.83M | 51.22M | 65.83M |
# of Estimates | 6 | 6 | 7 | 6 |
High Estimate | 27.91M | 27.91M | 75.00M | 100.00M |
Low Estimate | 5.00M | 5.00M | 29.20M | 20.00M |
Year ago Sales | 17.19M | 316.19M | 377.71M | 51.22M |
Year over Year Growth Est. | -13.54% | -94.99% | -86.44% | 28.53% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.13 | -1.11 | -4.60 | -4.43 |
# of Estimates | 8 | 7 | 9 | 7 |
Most Recent Consensus | -0.98 | -0.95 | -4.24 | -3.55 |
High Estimate | -0.94 | -0.94 | -4.19 | -3.53 |
Low Estimate | -1.33 | -1.31 | -4.97 | -5.06 |
Year ago EPS | -1.22 | 1.73 | -1.72 | -4.60 |
Year over Year Growth Est. | 7.38% | -164.16% | -167.44% | 3.67% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.13 | -1.11 | -4.60 | -4.43 |
7 Days Ago | -1.13 | -1.11 | -4.60 | -4.43 |
30 Days Ago | -1.13 | -1.11 | -4.60 | -4.43 |
60 Days Ago | -1.13 | -1.11 | -4.60 | -4.43 |
90 Days Ago | -1.15 | -1.16 | -4.68 | -4.66 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.13 | -1.11 | -4.60 | -4.43 |
Zacks Consensus Estimate | -1.13 | -1.11 | -4.60 | -4.43 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.11 | -1.21 | 1.73 | -1.22 | NA |
Estimate | -1.13 | -1.45 | -1.15 | -1.37 | NA |
Difference | 0.02 | 0.24 | 2.88 | 0.15 | 0.82 |
Surprise | 1.77% | 16.55% | 250.43% | 10.95% | 69.93% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more